197 related articles for article (PubMed ID: 23916409)
21. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
22. [Motivational interventions: psychosis and cannabis].
Favrod J
Encephale; 2009 Dec; 35 Suppl 6():S209-13. PubMed ID: 20141773
[TBL] [Abstract][Full Text] [Related]
23. Cannabis and psychiatric disorders: it is not only addiction.
Leweke FM; Koethe D
Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
[TBL] [Abstract][Full Text] [Related]
24. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.
Malone DT; Hill MN; Rubino T
Br J Pharmacol; 2010 Jun; 160(3):511-22. PubMed ID: 20590561
[TBL] [Abstract][Full Text] [Related]
25. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
[TBL] [Abstract][Full Text] [Related]
26. [Permanent psychiatric effects in former addicts to marijuana or stimulants].
Goldchluk A; Herbst L
Vertex; 2008; 19(77):503-11. PubMed ID: 18443664
[TBL] [Abstract][Full Text] [Related]
27. [Cannabis and schizophrenia. From euphoria to psychosis].
Berger N
Rev Med Liege; 2004 Feb; 59(2):98-103. PubMed ID: 15112899
[TBL] [Abstract][Full Text] [Related]
28. Cannabis and adolescent brain development.
Lubman DI; Cheetham A; Yücel M
Pharmacol Ther; 2015 Apr; 148():1-16. PubMed ID: 25460036
[TBL] [Abstract][Full Text] [Related]
29. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
Di Forti M; Morrison PD; Butt A; Murray RM
Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
[TBL] [Abstract][Full Text] [Related]
30. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
Schneider M
Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
[TBL] [Abstract][Full Text] [Related]
31. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls.
Rentzsch J; Penzhorn A; Kernbichler K; Plöckl D; Gómez-Carrillo de Castro A; Gallinat J; Jockers-Scherübl MC
Exp Neurol; 2007 May; 205(1):241-9. PubMed ID: 17368620
[TBL] [Abstract][Full Text] [Related]
32. [Is cannabis a vulnerability factor in schizophrenic disorders].
Laqueille X
Arch Pediatr; 2009 Sep; 16(9):1302-5. PubMed ID: 19640690
[TBL] [Abstract][Full Text] [Related]
33. [The role of cannabis use in psychosis].
Pajkossy P; Demetrovics Z
Psychiatr Hung; 2007; 22(2):145-62. PubMed ID: 17895537
[TBL] [Abstract][Full Text] [Related]
34. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
[TBL] [Abstract][Full Text] [Related]
35. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
Lecardeur L; Meunier-Cussac S; Dollfus S
Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
[TBL] [Abstract][Full Text] [Related]
36. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
Cohen M; Solowij N; Carr V
Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
[TBL] [Abstract][Full Text] [Related]
37. Schizophrenia and cannabis use.
Kumra S
Minn Med; 2007 Jan; 90(1):36-8. PubMed ID: 17305103
[TBL] [Abstract][Full Text] [Related]
38. Interpreting the association between cannabis use and increased risk for schizophrenia.
Weiser M; Noy S
Dialogues Clin Neurosci; 2005; 7(1):81-5. PubMed ID: 16060598
[TBL] [Abstract][Full Text] [Related]
39. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
40. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
